{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:39:43Z","timestamp":1793137183710,"version":"4.5.0"},"reference-count":31,"publisher":"Japanese Society for Magnetic Resonance in Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MRMS","magn reson med sci"],"published-print":{"date-parts":[[2021]]},"DOI":"10.2463\/mrms.mp.2020-0063","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T22:06:44Z","timestamp":1599430004000},"page":"295-302","source":"Crossref","is-referenced-by-count":21,"title":["Potential of Liver T&lt;sub&gt;1&lt;\/sub&gt; Mapping for the Detection of Fontan-associated Liver Disease in Adults"],"prefix":"10.2463","volume":"20","author":[{"given":"Yumi","family":"Shiina","sequence":"first","affiliation":[{"name":"Department of Pediatric Cardiology and Adult Congenital Cardiology, Tokyo Women\u2019s Medical University"},{"name":"Cardiovascular Center, St. Luke\u2019s International Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Inai","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology and Adult Congenital Cardiology, Tokyo Women\u2019s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging &amp; Nuclear Medicine, Tokyo Women\u2019s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinobu","family":"Nagao","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging &amp; Nuclear Medicine, Tokyo Women\u2019s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1295","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gordon-Walker TT, Bove K, Veldtman G. Fontan-associated liver disease: a review. J Cardiol 2019; 74:223\u2013232.","DOI":"10.1016\/j.jjcc.2019.02.016"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Johnson JA, Cetta F, Graham RP, et al. Identifying predictors of hepatic disease in patients after the Fontan operation: a postmortem analysis. J Thorac Cardiovasc Surg 2013; 146:140\u2013145.","DOI":"10.1016\/j.jtcvs.2012.09.005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 2005; 129:1348\u20131352.","DOI":"10.1016\/j.jtcvs.2004.10.005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kiesewetter CH, Sheron N, Vettukattill JJ, et al. Hepatic changes in the failing Fontan circulation. Heart 2007; 93:579\u2013584.","DOI":"10.1136\/hrt.2006.094516"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kendall TJ, Stedman B, Hacking N, et al. Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study. J Clin Pathol 2008; 61:504\u2013508.","DOI":"10.1136\/jcp.2007.052365"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Goldberg DJ, Surrey LF, Glatz AC, et al. Hepatic fibrosis is universal following Fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study. J Am Heart Assoc 2017; 6:e004809.","DOI":"10.1161\/JAHA.116.004809"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pundi K, Pundi KN, Kamath PS, et al. Liver disease in patients after the Fontan operation. Am J Cardiol 2016; 117:456\u2013460.","DOI":"10.1016\/j.amjcard.2015.11.014"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nandwana SB, Olaiya B, Cox K, Sahu A, Mittal P. Abdominal imaging surveillance in adult patients after Fontan procedure: risk of chronic liver disease and hepatocellular carcinoma. Curr Probl Diagn Radiol 2018; 47:19\u201322.","DOI":"10.1067\/j.cpradiol.2017.04.002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Asrani SK, Warnes CA, Kamath PS. Hepatocellular carcinoma after the Fontan procedure. N Engl J Med 2013; 368:1756\u20131757.","DOI":"10.1056\/NEJMc1214222"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bae JM, Jeon TY, Kim JS, et al. Fontan-associated liver disease: spectrum of US findings. Eur J Radiol 2016; 85:850\u2013856.","DOI":"10.1016\/j.ejrad.2016.02.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Bulut OP, Romero R, Mahle WT, et al. Magnetic resonance imaging identifies unsuspected liver abnormalities in patients after the Fontan procedure. J Pediatr 2013; 163:201\u2013206.","DOI":"10.1016\/j.jpeds.2012.12.071"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wolff D, van Melle JP, Dijkstra H, et al. The Fontan circulation and the liver: a magnetic resonance diffusion-weighted imaging study. Int J Cardiol 2016; 202:595\u2013600.","DOI":"10.1016\/j.ijcard.2015.09.088"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Wallihan DB, Podberesky DJ, Marino BS, Sticka JS, Serai S. Relationship of MR elastography determined liver stiffness with cardiac function after Fontan palliation. J Magn Reson Imaging 2014; 40:1328\u20131335.","DOI":"10.1002\/jmri.24496"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Poterucha JT, Johnson JN, Qureshi MY, et al. Magnetic resonance elastography: a novel technique for the detection of hepatic fibrosis and hepatocellular carcinoma after the Fontan operation. Mayo Clin Proc 2015; 90:882\u2013894.","DOI":"10.1016\/j.mayocp.2015.04.020"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zhu L, Lai Y, Makowski M, et al. Native T<sub>1<\/sub> mapping of autoimmune pancreatitis as a quantitative outcome surrogate. Eur Radiol 2019; 29:4436\u20134446.","DOI":"10.1007\/s00330-018-5987-9"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Li J, Liu H, Zhang C, et al. Native T<sub>1<\/sub> mapping compared to ultrasound elastography for staging and monitoring liver fibrosis: an animal study of repeatability, reproducibility, and accuracy. Eur Radiol 2020; 30:337\u2013345.","DOI":"10.1007\/s00330-019-06335-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. de Lange C, Reichert MJE, Pagano JJ, et al. Increased extracellular volume in the liver of pediatric Fontan patients. J Cardiovasc Magn Reson 2019; 21:39.","DOI":"10.1186\/s12968-019-0545-4"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ramachandran P, Serai SD, Veldtman GR, et al. Assessment of liver T<sub>1<\/sub> mapping in fontan patients and its correlation with magnetic resonance elastography-derived liver stiffness. Abdom Radiol (NY) 2019; 44:2403\u20132408.","DOI":"10.1007\/s00261-019-01990-9"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yamamura K, Sakamoto I, Morihana E, et al. Elevated non-invasive liver fibrosis markers and risk of liver carcinoma in adult patients after repair of tetralogy of Fallot. Int J Cardiol 2019; 287:121\u2013126.","DOI":"10.1016\/j.ijcard.2019.04.032"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Fragaki M, Sifaki-Pistolla D, Orfanoudaki E, Kouroumalis E. Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative? Ann Gastroenterol 2019; 32:626\u2013632.","DOI":"10.20524\/aog.2019.0417"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Deng M, Ng SWY, Cheung ST, Chong CCN. Clinical application of Albumin-Bilirubin (ALBI) score: the current status. Surgeon 2020; 18:178\u2013186.","DOI":"10.1016\/j.surge.2019.09.002"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Evans WN, Acherman RJ, Ciccolo ML, et al. MELD-XI scores correlate with post-Fontan hepatic biopsy fibrosis scores. Pediatr Cardiol 2016; 37:1274\u20131277.","DOI":"10.1007\/s00246-016-1428-1"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Assenza GE, Graham DA, Landzberg MJ, et al. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart 2013; 99:491\u2013496.","DOI":"10.1136\/heartjnl-2012-303347"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kellman P, Hansen MS. T<sub>1<\/sub>-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson 2014; 16:2.","DOI":"10.1186\/1532-429X-16-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Shiina Y, Inai K, Taniguchi K, Takahashi T, Nagao M. Potential value of native T<sub>1<\/sub> mapping in symptomatic adults with congenital heart disease: a preliminary study of 3.0 tesla cardiac magnetic resonance imaging. Pedatric Cardiol 2020; 41:94\u2013100.","DOI":"10.1007\/s00246-019-02227-8"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Chung C, Iwakiri Y. The lymphatic vascular system in liver diseases: its role in ascites formation. Clin Mol Hepatol 2013; 19:99\u2013104.","DOI":"10.3350\/cmh.2013.19.2.99"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tanaka M, Iwakiri Y. The hepatic lymphatic vascular system: structure, function, markers, and lymphangiogenesis. Cell Mol Gastroenterol Hepatol 2016; 2:733\u2013749.","DOI":"10.1016\/j.jcmgh.2016.09.002"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Hoffman DH, Ayoola A, Nickel D, Han F, Chandarana H, Shanbhogue KP. T<sub>1<\/sub> mapping, T<sub>2<\/sub> mapping and MR elastography of the liver for detection and staging of liver fibrosis. Abdom Radiol (NY) 2020; 45:692\u2013700.","DOI":"10.1007\/s00261-019-02382-9"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Luetkens JA, Klein S, Tr\u00e4ber F, et al. Quantification of liver fibrosis at T<sub>1<\/sub> and T<sub>2<\/sub> mapping with extracellular volume fraction MRI: preclinical results. Radiology 2018; 288:748\u2013754.","DOI":"10.1148\/radiol.2018180051"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Shimizu M, Miyamoto K, Nishihara Y, et al. Risk factors and serological markers of liver cirrhosis after Fontan procedure. Heart Vessels 2016; 31:1514\u20131521.","DOI":"10.1007\/s00380-015-0743-4"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Nakamori S, Dohi K, Ishida M, et al. Native T<sub>1<\/sub> mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy. JACC Cardiovasc Imaging 2018; 11:48\u201359.","DOI":"10.1016\/j.jcmg.2017.04.006"}],"container-title":["Magnetic Resonance in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/20\/3\/20_mp.2020-0063\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T05:23:46Z","timestamp":1715145826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/20\/3\/20_mp.2020-0063\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2463\/mrms.mp.2020-0063","relation":{},"ISSN":["1347-3182","1880-2206"],"issn-type":[{"value":"1347-3182","type":"print"},{"value":"1880-2206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"mp.2020-0063"}}